Life Science News

RSS

AI used to build a 3D model of the Commander complex

University of Queensland researchers have used artificial intelligence to build a 3D map of key cell components to better understand dementia and infectious diseases including COVID-19.

11 May 2023

Extracellular chaperones mediate the lysosomal degradation of misfolded proteins

When exposed to stressful conditions, several proteins tend to misfold and form aggregates inside or outside cells.

11 May 2023

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.

11 May 2023

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

11 May 2023

New NIH program seeks to discover and catalog the breadth of somatic mosaicism in human tissues

The National Institutes of Health is launching a new program, the Common Fund's Somatic Mosaicism Across Human Tissues Network, that aims to transform our knowledge of how much genetic variation there is in the cells and tissues throughout our bodies.

11 May 2023

Leaves of the Labrador tea plant contain an essential oil that could help combat malaria

Much of what is now considered modern medicine originated as folk remedies or traditional, Indigenous practices. These customs are still alive today, and they could help address a variety of conditions.

11 May 2023

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

Cellular Origins a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs).

From Cellular Origins 11 May 2023

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

From ELRIG (UK) Ltd. 11 May 2023

What are the potential consequences of unchecked AI proliferation?

Research paper discusses the potential threats posed by artificial intelligence (AI) to human health and well-being, including control and manipulation of people, dehumanizing lethal weapon capacity, and rendering human labor obsolete. It also highlights the need for effective regulation and calls for a moratorium on the development of self-improving AI.

11 May 2023

Researchers advance the understanding of sperm maturation

Fertility has long been cherished across humankind. Now, in a study published in Nature Communications, researchers from Osaka University have furthered our understanding of sperm maturation.

10 May 2023

New advanced AI system shows accuracy and speed in identifying protein patterns

A new advanced artificial intelligence (AI) system has shown world-leading accuracy and speed in identifying protein patterns within individual cells.

10 May 2023

Neanderthal genes shape human noses

Research reports a study on the genetics of facial features in Latin Americans using automatic landmarking of 2D portraits and genome-wide association analysis. The study identified novel regions associated with facial features, including a region in 1q32.3 that shows introgression from Neanderthals and influences nasal height.

10 May 2023

New approaches to promote healthspan from an epigenetic perspective

A new review paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 8, entitled, "How can we modulate aging through nutrition and physical exercise? An epigenetic approach."

10 May 2023

New drug delivery system delivers antioxidant directly to mitochondria in the liver

A new drug delivery system delivers an antioxidant directly to mitochondria in the liver, mitigating the effects of oxidative stress.

10 May 2023

Specially designed capsule gives a fuller picture of normal digestion in healthy people

Using a specially designed capsule, researchers can now voyage through the digestive system, collecting new data about digestion and microorganisms.

10 May 2023

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting."

10 May 2023

Schlafen 12 identified as a novel HIV restriction factor

An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor.

10 May 2023

Researchers create new "pangenome" that provides better view of human genome

When it was launched in April 2003, the Human Genome Project helped revolutionize biomedical research by providing scientists a reference map that allowed them to analyze DNA sequences for genetic clues to the origins of a host of diseases.

10 May 2023

Researchers release new high-quality collection of reference human genome sequences

Researchers have released a new high-quality collection of reference human genome sequences that captures substantially more diversity from different human populations than what was previously available.

10 May 2023

MGI launches overseas production line of DNBSEQ-G400* sequencer in Latvia

Riga, Latvia, 8 May 2023 – LATVIA MGI TECH, SIA, ("MGI Latvia") a subsidiary of MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today announced the official opening of its large-scale production line in Latvia. As MGI's largest regional hub for the European market, the facility based in Riga will see assembly and production of DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents.

From MGI 10 May 2023

Life Science News

AI used to build a 3D model of the Commander complex

Extracellular chaperones mediate the lysosomal degradation of misfolded proteins

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Targeting uncontrolled inflammation may make tumors more responsive to treatment

New NIH program seeks to discover and catalog the breadth of somatic mosaicism in human tissues

Leaves of the Labrador tea plant contain an essential oil that could help combat malaria

Cellular Origins partners with ScaleReady to simplify, standardise, and automate cell therapy manufacturing

ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

What are the potential consequences of unchecked AI proliferation?

Researchers advance the understanding of sperm maturation

New advanced AI system shows accuracy and speed in identifying protein patterns

Neanderthal genes shape human noses

New approaches to promote healthspan from an epigenetic perspective

New drug delivery system delivers antioxidant directly to mitochondria in the liver

Specially designed capsule gives a fuller picture of normal digestion in healthy people

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

Schlafen 12 identified as a novel HIV restriction factor

Researchers create new "pangenome" that provides better view of human genome

Researchers release new high-quality collection of reference human genome sequences

MGI launches overseas production line of DNBSEQ-G400* sequencer in Latvia

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest Life Science News